ALPN Annual CFF
$165.12 M
+$62.43 M+60.80%
31 December 2023
Summary:
As of February 5, 2025, ALPN annual cash flow from financing activities is $165.12 million, with the most recent change of +$62.43 million (+60.80%) on December 31, 2023. During the last 3 years, it has risen by +$103.74 million (+169.01%).ALPN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALPN Quarterly CFF
$19.35 M
-$137.26 M-87.64%
01 March 2024
Summary:
As of February 5, 2025, ALPN quarterly cash flow from financing activities is $19.35 million, with the most recent change of -$137.26 million (-87.64%) on March 1, 2024. Over the past year, it has increased by +$18.15 million (+1511.24%).ALPN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALPN TTM CFF
$185.56 M
+$20.44 M+12.38%
01 March 2024
Summary:
As of February 5, 2025, ALPN TTM cash flow from financing activities is $185.56 million, with the most recent change of +$20.44 million (+12.38%) on March 1, 2024. Over the past year, it has increased by +$165.50 million (+825.26%).ALPN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALPN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.8% | +1511.2% | +825.3% |
| 3 y3 years | +169.0% | +1511.2% | +825.3% |
| 5 y5 years | +10000.0% | +1511.2% | +825.3% |
ALPN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -87.6% | at high |
Alpine Immune Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $19.35 M(-87.6%) | $185.56 M(+12.4%) |
| Dec 2023 | $165.12 M(+60.8%) | $156.61 M(>+9900.0%) | $165.12 M(+723.3%) |
| Sept 2023 | - | $1.20 M(-85.7%) | $20.05 M(-82.0%) |
| June 2023 | - | $8.40 M(-872.6%) | $111.67 M(+9.2%) |
| Mar 2023 | - | -$1.09 M(-109.4%) | $102.25 M(-0.4%) |
| Dec 2022 | $102.69 M(+1.9%) | $11.54 M(-87.6%) | $102.69 M(+0.7%) |
| Sept 2022 | - | $92.82 M(-9199.6%) | $102.02 M(+3.2%) |
| June 2022 | - | -$1.02 M(+56.9%) | $98.88 M(-1.0%) |
| Mar 2022 | - | -$650.00 K(-106.0%) | $99.91 M(-0.8%) |
| Dec 2021 | $100.76 M(+64.2%) | $10.87 M(-87.9%) | $100.76 M(+12.1%) |
| Sept 2021 | - | $89.68 M(>+9900.0%) | $89.88 M(+58.8%) |
| June 2021 | - | $9000.00(-95.5%) | $56.59 M(+0.0%) |
| Mar 2021 | - | $202.00 K(-1936.4%) | $56.58 M(-7.8%) |
| Dec 2020 | $61.38 M(+153.1%) | -$11.00 K(-100.0%) | $61.38 M(-0.0%) |
| Sept 2020 | - | $56.39 M(>+9900.0%) | $61.39 M(+823.5%) |
| June 2020 | - | $2000.00(-100.0%) | $6.65 M(+8.3%) |
| Mar 2020 | - | $5.00 M(>+9900.0%) | $6.14 M(-74.7%) |
| Dec 2019 | $24.25 M | $0.00(-100.0%) | $24.25 M(+2.1%) |
| Sept 2019 | - | $1.65 M(-423.4%) | $23.75 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$509.00 K(-102.2%) | $21.61 M(-2.3%) |
| Mar 2019 | - | $23.12 M(-4723.6%) | $22.12 M(-2332.1%) |
| Dec 2018 | -$991.00 K(-102.3%) | -$500.00 K(+0.4%) | -$991.00 K(+101.8%) |
| Sept 2018 | - | -$498.00 K(<-9900.0%) | -$491.00 K(-101.2%) |
| June 2018 | - | $0.00(-100.0%) | $42.70 M(0.0%) |
| Mar 2018 | - | $7000.00(>+9900.0%) | $42.70 M(+0.0%) |
| Dec 2017 | $42.69 M(>+9900.0%) | $0.00(-100.0%) | $42.69 M(-0.1%) |
| Sept 2017 | - | $42.69 M(>+9900.0%) | $42.75 M(>+9900.0%) |
| Dec 2016 | $166.00 K(-99.8%) | $63.00 K(+472.7%) | $166.00 K(+0.6%) |
| Sept 2016 | - | $11.00 K(-88.0%) | $165.00 K(-108.5%) |
| June 2016 | - | $92.00 K(+48.4%) | -$1.95 M(-102.5%) |
| Dec 2015 | $78.83 M(+91.5%) | $62.00 K(-102.9%) | $78.83 M(-27.5%) |
| Sept 2015 | - | -$2.10 M(-102.6%) | $108.67 M(-5.4%) |
| June 2015 | - | $80.88 M(+170.6%) | $114.86 M(+179.0%) |
| Dec 2014 | $41.17 M(+280.8%) | $29.89 M(+631.2%) | $41.17 M(+265.2%) |
| Sept 2014 | - | $4.09 M(+57.0%) | $11.27 M(+56.9%) |
| June 2014 | - | $2.60 M(-43.2%) | $7.18 M(+56.8%) |
| Mar 2014 | - | $4.58 M | $4.58 M |
| Dec 2013 | $10.81 M(-7.3%) | - | - |
| Dec 2012 | $11.66 M | - | - |
FAQ
- What is Alpine Immune Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for Alpine Immune Sciences?
- What is Alpine Immune Sciences annual CFF year-on-year change?
- What is Alpine Immune Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Alpine Immune Sciences?
- What is Alpine Immune Sciences quarterly CFF year-on-year change?
- What is Alpine Immune Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Alpine Immune Sciences?
- What is Alpine Immune Sciences TTM CFF year-on-year change?
What is Alpine Immune Sciences annual cash flow from financing activities?
The current annual CFF of ALPN is $165.12 M
What is the all time high annual CFF for Alpine Immune Sciences?
Alpine Immune Sciences all-time high annual cash flow from financing activities is $165.12 M
What is Alpine Immune Sciences annual CFF year-on-year change?
Over the past year, ALPN annual cash flow from financing activities has changed by +$62.43 M (+60.80%)
What is Alpine Immune Sciences quarterly cash flow from financing activities?
The current quarterly CFF of ALPN is $19.35 M
What is the all time high quarterly CFF for Alpine Immune Sciences?
Alpine Immune Sciences all-time high quarterly cash flow from financing activities is $156.61 M
What is Alpine Immune Sciences quarterly CFF year-on-year change?
Over the past year, ALPN quarterly cash flow from financing activities has changed by +$18.15 M (+1511.24%)
What is Alpine Immune Sciences TTM cash flow from financing activities?
The current TTM CFF of ALPN is $185.56 M
What is the all time high TTM CFF for Alpine Immune Sciences?
Alpine Immune Sciences all-time high TTM cash flow from financing activities is $185.56 M
What is Alpine Immune Sciences TTM CFF year-on-year change?
Over the past year, ALPN TTM cash flow from financing activities has changed by +$165.50 M (+825.26%)